There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Illumina, Inc. (NASDAQ: ILMN) According to reports, Roche Holding AG has offered to buy Illumina Incorporated - symbol ILMN - for $44.50 per share in cash, or for a total amount of about $5.7 billion ILMN is a leading developer, manufacturer, and...
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Swiss-based Roche Holding AG is offering on January 25, 2012, USD 5.7 billion in cash to buy U.S. gene-sequencing company Illumina Inc in a hostile... View Photo »
The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel in this February 4, 2009 file photo. Swiss-based Roche Holding AG is offering on January 25, 2012, USD 5.7 billion in cash to buy U.S. gene-sequencing... View Photo »
ZURICH/LONDON (Reuters) - Roche Holding AG (ROG.VX) is offering $5.7 billion (3.6 billion pound) in cash to buy U.S. gene sequencing company Illumina Inc (ILMN.O) in an unsolicited takeover bid that marks a major play by the Swiss drugmaker in the gene...
YORK--(BUSINESS WIRE)--Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Illumina, Inc. On January 25, 2012, Roche announced that it offered to acquire all of Illumina’s outstanding shares for $44.50...
There are no results for this module. Edit this module to change the search term used to query Wikipedia
The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel in this February 4, 2009 file photo. Swiss-based Roche Holding AG is offering on January 25, 2012, USD 5.7 billion in cash to buy U.S. gene-sequencing company Illumina Inc in a hostile...
View Photo »FILE - In this March 16 2006 file picture the Roche buildings in Basel, Switzerland. Swiss drug maker Roche Holding AG on Thursday Oct. 13, 2011, posted a 14 percent drop in year-on-year sales for the first nine months of 2011, blaming Switzerland's strong currency for weakening its...
View Photo »Franz B. Humer, chairman of the board of Roche, right, and CEO Severin Schwan attend the general assembly of Swiss pharmaceutical company Roche Holding AG in Basel, Switzerland, Tuesday, March 1, 2011.
View Photo »Franz B. Humer, chairman of the board of Roche, speaks during the general assembly of Swiss pharmaceutical company Roche Holding AG in Basel, Switzerland, Tuesday, March 1, 2011.
View Photo »File picture shows a worker making his way on a bridge at Swiss pharmaceutical company Roche plant in Basel February 2, 2011. Swiss drugmaker Roche Holding AG raised its full-year earnings target for 2011 July 21, 2011, as cost-cutting protected its first-half profitability from the...
View Photo »File picture shows the logo of the Swiss drugmaker Roche on a factory in Burgdorf near Bern November 17, 2010. Swiss drugmaker Roche Holding AG raised its full-year earnings target for 2011 on Thursday as cost-cutting protected its first-half profitability from the impact of the strong...
View Photo »The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel in this February 4, 2009 file photo. Swiss-based Roche Holding AG is offering on January 25, 2012, USD 5.7 billion in cash to buy U.S. gene-sequencing company Illumina Inc in a hostile...
View Photo »There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to Roche Holding.
